Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ritzau

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Clinical Pharmacology|May 29, 1998
Analgesic dose-response relationship of ibuprofen 50, 100, 200, and 400 mg after surgical removal of third molars: a single-dose, randomized, placebo-controlled, and double-blind study of 304 patientsS Schou, H Nielsen, A Nattestad, et al.
The Journal of Antibiotics|February 1, 1995
Helioferins; novel antifungal lipopeptides from Mycogone rosea: screening, isolation, structures and biological propertiesU Gräfe, W Ihn, M Ritzau, et al.
The Journal of Antibiotics|July 1, 1992
Metabolic products of microorganisms. 261. Obscurolides, a novel class of phosphodiesterase inhibitors from streptomyces. I. Production, isolation, structural elucidation and biological activity of obscurolides A1 to A4H Hoff, H Drautz, H P Fiedler, et al.
The Journal of Antibiotics|February 1, 1995
Aurantimycins, new depsipeptide antibiotics from Streptomyces aurantiacus IMET 43917. Production, isolation, structure elucidation, and biological activityU Gräfe, R Schlegel, M Ritzau, et al.
The Journal of Antibiotics|May 1, 1997
Lipohexin, a new inhibitor of prolyl endopeptidase from Moeszia lindtneri (HKI-0054) and Paecilomyces sp. (HKI-0055; HKI-0096). I. Screening, isolation and structure elucidationS Heinze, M Ritzau, W Ihn, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Clinical Pharmacology|May 29, 1998
Analgesic dose-response relationship of ibuprofen 50, 100, 200, and 400 mg after surgical removal of third molars: a single-dose, randomized, placebo-controlled, and double-blind study of 304 patientsS Schou, H Nielsen, A Nattestad, et al.
The Journal of Antibiotics|February 1, 1995
Helioferins; novel antifungal lipopeptides from Mycogone rosea: screening, isolation, structures and biological propertiesU Gräfe, W Ihn, M Ritzau, et al.
The Journal of Antibiotics|July 1, 1992
Metabolic products of microorganisms. 261. Obscurolides, a novel class of phosphodiesterase inhibitors from streptomyces. I. Production, isolation, structural elucidation and biological activity of obscurolides A1 to A4H Hoff, H Drautz, H P Fiedler, et al.
The Journal of Antibiotics|February 1, 1995
Aurantimycins, new depsipeptide antibiotics from Streptomyces aurantiacus IMET 43917. Production, isolation, structure elucidation, and biological activityU Gräfe, R Schlegel, M Ritzau, et al.
The Journal of Antibiotics|May 1, 1997
Lipohexin, a new inhibitor of prolyl endopeptidase from Moeszia lindtneri (HKI-0054) and Paecilomyces sp. (HKI-0055; HKI-0096). I. Screening, isolation and structure elucidationS Heinze, M Ritzau, W Ihn, et al.
Pageof 5